We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WST icon
726
West Pharmaceutical
WST
$24.7B
-1,156
Closed -$284K
WU icon
727
Western Union
WU
$2.21B
-15,000
Closed -$207K
XLK icon
728
State Street Technology Select Sector SPDR ETF
XLK
$122B
-4,000
Closed -$238K
ZBH icon
729
Zimmer Biomet
ZBH
$18.6B
-3,632
Closed -$380K
BNAI
730
Brand Engagement Network
BNAI
$101M
-1,077
Closed -$107K
DJTWW
731
Trump Media & Technology Group Warrants
DJTWW
$733M
-33,419
Closed -$120K
VEEA
732
Veea Inc
VEEA
$7.59M
-25,000
Closed -$248K
RDW.WS
733
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
-21,158
Closed -$7K
NAPA
734
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
-56,000
Closed -$808K
KACLR
735
DELISTED
Kairous Acquisition Corp. Limited Rights
KACLR
-37,500
Closed -$3K
CTLT
736
DELISTED
CATALENT, INC.
CTLT
-3,021
Closed -$219K
FEXDR
737
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
-278,599
Closed -$42K
PRST
738
DELISTED
Presto Technologies, Inc. Common Stock
PRST
-10,763
Closed -$22K
GMFIW
739
DELISTED
Aetherium Acquisition Corp Warrant
GMFIW
-72,700
Closed -$5K
BREZR
740
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
-188,959
Closed -$8K
CONXU
741
DELISTED
CONX Corp. Unit
CONXU
-228,480
Closed -$2.29M
ROSS
742
DELISTED
Ross Acquisition Corp II
ROSS
-113,871
Closed -$1.13M
ALTU
743
DELISTED
Altitude Acquisition Corp
ALTU
-200,000
Closed -$2.01M
SNCE
744
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
-23,313
Closed -$751K
LBBBR
745
DELISTED
Lakeshore Acquisition II Corp. Rights
LBBBR
-157,206
Closed -$29K
IRRX.WS
746
DELISTED
Integrated Rail and Resources Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
IRRX.WS
-39,500
Closed -$3K
LCAA
747
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
-100,000
Closed -$991K
MTRYW
748
DELISTED
Monterey Innovation Acquisition Corp. Warrant
MTRYW
-19,100
Closed -$1K
EQRXW
749
DELISTED
EQRx, Inc. Warrant
EQRXW
-89,641
Closed -$74K
ICPT
750
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-57,300
Closed -$13K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.